Preventive effects of Hangeshashinto for oral mucositis in Hematopoietic Stem Cell Transplantation Recipients

JRCT ID: jRCTs071200012

Registered date:07/05/2020

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Patients who will undergo allogeneic hematopoietic stem cell transplantation
• Date of first enrollment: 10/07/2020
• Target sample size: 30
• Study type: Interventional
• Intervention(s): Gargling with Hangeshashinto

Outcome(s)

• Primary Outcome: Incidence and onset timing of grade 2 oral mucositis
• Secondary Outcome: Incidence and onset timing of grade 1,3,4 and 5 oral mucositis

Key inclusion & exclusion criteria

• Age minimum: >= 16age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Patients who will undergo allogeneic hematopoietic stem cell transplantation
• Exclude criteria: Patients with problem in judgement

Related Information

• Primary Sponsor: Yoshimatsu Masako